Gerard van Odijk
Member of the board since 2008.
Re-elected in 2010 for a one-year term. Independent.
Mr. van Odijk is President and CEO of Teva Pharmaceuticals
Europe B.V. Mr. van Odijk's international executive career has led
to a variety of senior positions in GlaxoSmithKline (GSK).
He holds a medical degree from the State University of
Utrecht.
Mr. van Odijk is Chairman of the Board of Merus
Biopharmaceuticals B.V.
Mr. van Odijk is a Dutch national, born in 1957.
The special competences possessed by Mr. van Odijk that are
important for the performance of his duties are his medical
qualifications and his extensive executive background within the
international pharmaceutical industry.
